ISIN | CH0368190739 |
---|---|
Valor Number | 36819073 |
Bloomberg Global ID | CHSRI SW |
Fund Name | UBS ETF (CH) - MSCI Switzerland IMI Socially Responsible (CHF) A-dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 17.75 CHF | 06.09.2024 |
---|---|---|
Previous Price * | 18.35 CHF | 05.09.2024 |
52 Week High * | 18.79 CHF | 02.09.2024 |
52 Week Low * | 14.84 CHF | 20.10.2023 |
NAV * | 17.75 CHF | 06.09.2024 |
Issue Price * | 17.75 CHF | 06.09.2024 |
Redemption Price * | 17.75 CHF | 06.09.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 789,399,197 | |
Unit/Share Assets *** | 571,547,807 | |
Trading Information SIX |
YTD Performance | +8.10% |
29.12.2023 - 06.09.2024
29.12.2023 06.09.2024 |
---|---|---|
1 month | +1.66% |
06.08.2024 - 06.09.2024
06.08.2024 06.09.2024 |
3 months | -3.28% |
06.06.2024 - 06.09.2024
06.06.2024 06.09.2024 |
6 months | +5.11% |
06.03.2024 - 06.09.2024
06.03.2024 06.09.2024 |
1 year | +12.57% |
06.09.2023 - 06.09.2024
06.09.2023 06.09.2024 |
2 years | +18.19% |
06.09.2022 - 06.09.2024
06.09.2022 06.09.2024 |
3 years | -4.66% |
06.09.2021 - 06.09.2024
06.09.2021 06.09.2024 |
5 years | +45.41% |
06.09.2019 - 06.09.2024
06.09.2019 06.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 5.91% | |
---|---|---|
Lonza Group Ltd | 5.31% | |
Novartis AG Registered Shares | 5.22% | |
Swiss Re AG | 5.12% | |
Zurich Insurance Group AG | 5.03% | |
Alcon Inc | 4.90% | |
Givaudan SA | 4.88% | |
ABB Ltd | 4.83% | |
UBS Group AG | 4.64% | |
Sika AG | 4.61% | |
Last data update | 26.08.2024 |
TER | 0.28% |
---|---|
TER date | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.28% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |